# NovoTTF-200A Together With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed GBM

> **NCT03869242** · NA · UNKNOWN · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 60 (estimated)

## Conditions studied

- Glioblastoma

## Interventions

- **DEVICE:** NovoTTF-200A

## Key facts

- **NCT ID:** NCT03869242
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10-01
- **Primary completion:** 2021-03-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2019-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03869242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03869242, "NovoTTF-200A Together With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed GBM". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03869242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*